Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Watermark Medical Signs Contract With Coventry Health Care

RELATED NEWS
Trade CA now with 

Watermark Medical, Inc., a privately held helthcare information technology company, announced that it has signed a contract with Coventry Health Care to provide home sleep testing service for the diagnosis of obstructive sleep apnea or OSA.

The company said the agreement expands Coventry's ability to deliver diagnostic testing to its members in a home-based environment while potentially reducing long-term costs.

Under the new multiyear agreement, Watermark will work directly with Coventry's physician network to diagnose members in the comfort and convenience of their own home at a fraction of the cost of a traditional in-lab sleep study.

Watermark stated that it will deliver these services through its Mail-to-Patient division, which supports physicians who do not currently provide home sleep diagnostics for their patients. Physicians in Coventry's network can refer patients with symptoms of OSA to Watermark, and the company will ship their diagnostic test directly to the patient.

Click here to receive FREE breaking news email alerts for CA Technologies and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%. Here is a quick summary of the earnings reported after the bell on Nov. 24. 1. Amira Nature Foods Ltd (ANFI) reported net income for the second quarter of $8.3 million or $0.29 per share, compared to $5.0 million or $0.18 per share for the year-ago quarter. Excluding items, adjusted earnings...
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.